TRRAP

Chr 7AD

transformation/transcription domain associated protein

Also known as: DEDDFA, DFNA75, PAF350/400, PAF400, STAF40, TR-AP, Tra1

The encoded protein is an adapter protein that recruits histone acetyltransferase complexes to chromatin for transcription activation and is required for MYC-, p53-, and E2F-mediated gene expression. Mutations cause autosomal dominant developmental delay with or without dysmorphic features and autism, as well as autosomal dominant deafness. This gene is highly constrained against loss-of-function variants (pLI = 1.0, LOEUF = 0.06), indicating that heterozygous loss is likely pathogenic.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismADLOEUF 0.062 OMIM phenotypes
Clinical SummaryTRRAP
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder with or without congenital anomalies · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
1 unique Pathogenic / Likely Pathogenic· 92 VUS of 200 total submissions
📖
GeneReview available — TRRAP
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint
0.06LOEUF
pLI 1.000
Z-score 12.59
OE 0.03 (0.020.06)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint
8.17Z-score
OE missense 0.52 (0.490.55)
1191 obs / 2292.1 exp
Constrained

Extremely missense-constrained (top ~0.01%)

Observed / Expected Ratios
LoF OE0.03 (0.020.06)
00.351.4
Missense OE0.52 (0.490.55)
00.61.4
Synonymous OE1.10
01.21.6
LoF obs/exp: 6 / 196.5Missense obs/exp: 1191 / 2292.1Syn Z: -2.45
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongTRRAP-related autism and syndromic intellectual disabilityOTHERAD
DN
0.3196th %ile
GOF
0.2597th %ile
LOF
0.79top 5%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · LOEUF 0.06
DN1 literature citation

Literature Evidence

DNConsistent with the dominant negative effect, the stable expression of an N-terminal p400 fragment showed a decrease in the association of p400 with ATM, but did not alter the association of p400 with TRRAP.PMID:27814680

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

200 submitted variants in ClinVar

Classification Summary

Pathogenic1
VUS92
Likely Benign101
Benign6
1
Pathogenic
92
VUS
101
Likely Benign
6
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
1
0
1
Likely Pathogenic
0
0
0
0
0
VUS
1
84
7
0
92
Likely Benign
0
0
44
57
101
Benign
0
0
3
3
6
Total1845560200

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TRRAP · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 5 full-text resultsSearch PubTator3 ↗